window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

News

NewsDebbie2026-02-23T12:06:10+00:00
  • All
  • Antibody drug conjugates
  • Artificial Intelligence
  • Biologics & Biosimilars
  • Biomanufacturing
  • Biotech
  • Cardiovascular diseases
  • CDMOs & Manufacturing
  • Cell & Gene Therapy
  • Central Nervous System
  • Child & Adolescnt Health
  • Chronic diseases
  • Clinical Development
  • Clinical studies
  • Clinical Trials
  • Data Management
  • Dermatology
  • Diagnostics
  • Digital Health
  • Drug approval
  • Drug Delivery & Formulation
  • Drug Development
  • Drug discovery
  • European biotech
  • Events and Conferences
  • Facilities and infrastructure
  • FDA
  • Funding
  • Gastroenterology
  • Genetic Diseases
  • Genomics and sequencing
  • Global health
  • Healthcare leadership
  • Hematology
  • Immunology
  • Infectious Diseases
  • Ingredients
  • Liver disease
  • Logistics and distribution
  • Manufacturing
  • Market Access & Commercialization
  • Medical devices
  • Mental health
  • Mergers & Acquisitions
  • Metabolic Diseases
  • Middle East
  • Movers & Shakers
  • Neurosciences
  • Obesity
  • Oncology
  • Opthalmology
  • Orphan drugs
  • Orthapaedics
  • Packaging
  • Partnerships & Funding
  • Patient Centricity
  • Peptides
  • Pharmaceuticals and therapeutics
  • Pharmacovigilance
  • Precision medicine
  • Psychadelics
  • Rare Diseases
  • Real world evidence
  • Regulatory Affairs
  • Research & Development
  • Respiratory
  • RNA Therapeutics
  • Single Cell analysis
  • Startups and innovations
  • Supply Chain & Logistics
  • Sustainability
  • Technology and platforms
  • Uncategorised
  • Vaccines
  • Women in Pharma
  • Women's Health
  • Chronic diseases,Drug approval,Drug Delivery & Formulation,Immunology,Pharmaceuticals and therapeutics,Respiratory

    Exdensur approved by European Commission for severe asthma and chronic rhinosinusitis with nasal polyps

    read more
  • Clinical Trials,Infectious Diseases,Pharmaceuticals and therapeutics,Research & Development

    ViiV Healthcare highlights ultra long-acting HIV pipeline and Phase 1 data at CROI 2026

    read more
  • Clinical Trials,FDA,Mental health,Neurosciences,Pharmaceuticals and therapeutics

    Compass Pathways reports positive second Phase 3 trial for COMP360 in treatment-resistant depression

    read more
  • Artificial Intelligence,Data Management,Digital Health,Pharmaceuticals and therapeutics,Technology and platforms

    Within3 launches Dataverse to integrate real-world data into pharma launch intelligence platform

    read more
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Facilities and infrastructure,Ingredients,Manufacturing,Technology and platforms

    DFE Pharma launches continuous manufacturing platform with Gericke to support formulation development

    read more
  • Artificial Intelligence,Clinical Development,Data Management,Digital Health,Healthcare leadership,Pharmaceuticals and therapeutics,Research & Development

    AI and medical affairs strategy set to redefine life sciences in 2026

    read more
  • Facilities and infrastructure,Global health,Manufacturing,Technology and platforms

    HORIBA to build new global headquarters to strengthen operations and drive innovation

    read more
  • Artificial Intelligence,Biotech,Drug Development,Partnerships & Funding,Research & Development,Technology and platforms

    Nuclera and leadXpro partner on AI-guided workflow for membrane protein drug discovery

    read more
  • Clinical Development,Clinical Trials,European biotech,Mental health,Neurosciences,Research & Development

    FundaMental Pharma to present FMP374 preclinical data in treatment-resistant depression at Bio-Neuroscience Conference

    read more
  • Clinical Trials,Oncology,Orphan drugs,Pharmaceuticals and therapeutics,Research & Development

    Oncoinvent to present 24-month Phase 1 ovarian cancer data for Radspherin at ESGO 2026

    read more
  • Cell & Gene Therapy,Clinical Development,Genetic Diseases,Research & Development

    Scribe Therapeutics secures milestone $1.5BN collaboration with Eli Lilly for in vivo CRISPR program

    read more
  • Funding,Medical devices,Neurosciences,Startups and innovations

    Neupulse secures £3M to advance neurotherapeutic device for Tourette Syndrome

    read more
  • Central Nervous System,Clinical Development,Clinical Trials,Funding

    Newron secures up to EUR 38 million to advance Phase 3 evenamide program in treatment-resistant schizophrenia

    read more
  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding,Rare Diseases

    Kidswell Bio and Treehill Partners launch US newco to advance cell therapy for paediatric cerebral palsy

    read more
  • Artificial Intelligence,Biotech,Central Nervous System,Clinical Development,Drug Development,Immunology,Pharmaceuticals and therapeutics,Technology and platforms

    Insilico Medicine and CMS announce AI-powered drug discovery collaborations in CNS and autoimmune diseases

    read more
  • Biomanufacturing,Cardiovascular diseases,Cell & Gene Therapy,Clinical Development

    CellProthera acquires full rights to transendocardial catheter from Celyad Oncology

    read more
Previous789Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Cereno Scientific reports long-term safety data from CS1 pulmonary arterial hypertension program
    Categories: Cardiovascular diseases, Clinical Trials, Rare Diseases, Regulatory Affairs, Research & Development
  • City St George’s and Paradigm Biopharmaceuticals study osteoarthritis pain drug mechanism
    Categories: Clinical Trials, Neurosciences, Partnerships & Funding, Research & Development
  • BIOGRUND and Seprify launch plant-based tablet coating to replace titanium dioxide
    Categories: Ingredients, Manufacturing, Packaging, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top